Biomedical Optics Express · 2015 · 45 citations · 33 references
MedicineDermatologyOncologyBiomedical ImagingDiagnostic ImagingMetastasisCancer DetectionCutaneous Metastatic DiseaseMelanocytic TumorsSentinel Lymph Node BiopsyTumor CharacterizationTumor ImagingChemical Diversity AnalysisMelanin AccumulationMelanin DepositionMelanoma DiagnosisMetastatic Potential AssessmentPrimary Skin LesionsSentinel Lymph Node Biopsy StagingSkin Tumor Imaging
Metastatic melanoma is associated with a poor prognosis, but no method reliably predicts which melanomas of a given stage will ultimately metastasize and which will not. While sentinel lymph node biopsy (SLNB) has emerged as the most powerful predictor of metastatic disease, the majority of people dying from metastatic melanoma still have a negative SLNB. Here we analyze pump-probe microscopy images of thin biopsy slides of primary melanomas to assess their metastatic potential. Pump-probe microscopy reveals detailed chemical information of melanin with subcellular spatial resolution. Quantification of the molecular signatures without reference standards is achieved using a geometrical representation of principal component analysis. Melanin structure is analyzed in unison with the chemical information by applying principles of mathematical morphology. Results show that melanin in metastatic primary lesions has lower chemical diversity than non-metastatic primary lesions, and contains two distinct phenotypes that are indicative of aggressive disease. Further, the mathematical morphology analysis reveals melanin in metastatic primary lesions has a distinct "dusty" quality. Finally, a statistical analysis shows that the combination of the chemical information with spatial structures predicts metastatic potential with much better sensitivity than SLNB and high specificity, suggesting pump-probe microscopy can be an important tool to help predict the metastatic potential of melanomas.
33
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch, Jeffrey E. Gershenwald, Seng-Jaw Soong et al. · Journal of Clinical Oncology · 2009 · 4.6K citations · Full text
Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
Keith T. Flaherty, J. Infante, Adil Daud et al. · New England Journal of Medicine · 2012 · 2.8K citations · Full text
Medicine, Oncology, Pharmacology +16
The histogenesis and biologic behavior of primary human malignant melanomas of the skin.
Wallace H. Clark, Lynn From, Evelina A. Bernardino et al. · PubMed · 1969 · 2.1K citations
Medicine, Dermatology, Pathology +17